Jens Hoeppner Selected Research

Jens Hoeppner Research Topics

22	Neoplasms (Cancer) 02/2022 - 02/2013
13	Adenocarcinoma 01/2023 - 03/2014
12	Esophageal Neoplasms (Esophageal Cancer) 09/2023 - 07/2013
5	Carcinoma (Carcinomatosis) 10/2022 - 12/2016
3	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2013
2	Stomach Neoplasms (Stomach Cancer) 10/2022 - 10/2022
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2021 - 12/2018
2	Circulating Neoplastic Cells 10/2019 - 05/2015
2	Chylothorax 06/2018 - 12/2013
1	Hiatal Hernia 09/2023
1	Esophageal Squamous Cell Carcinoma 02/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Aphasia (Dysphasia) 01/2022
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Leukopenia 01/2022
1	Paresis (Hemiparesis) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Inflammation (Inflammations) 02/2019
1	Fistula 12/2017
1	Empyema 12/2017
1	Abscess 12/2017
1	Pneumonia (Pneumonitis) 06/2017
1	Esophageal Stenosis (Esophageal Stricture) 02/2017
1	Deglutition Disorders (Dysphagia) 02/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Pneumoperitoneum 02/2016
1	Surgical Wound Infection 10/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2015
1	Anastomotic Leak 05/2014
1	Lymphatic Metastasis 06/2011
1	Ischemia 07/2009

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 08/2020 - 01/2016
2	Leucovorin (Folinic Acid)FDA Link 08/2020 - 01/2016
2	Azacitidine (5 Azacytidine)FDA Link 03/2016 - 01/2015
2	Histone Deacetylase InhibitorsIBA 03/2016 - 01/2015
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2020
1	Fluorouracil (Carac)FDA LinkGeneric 08/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	PlatinumIBA 04/2019
1	Cisplatin (Platino)FDA LinkGeneric 04/2019
1	CollagenIBA 02/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	DisintegrinsIBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019
1	PlasticsIBA 12/2017
1	Zinc Finger E-box-Binding Homeobox 1IBA 05/2017
1	Cadherins (E-Cadherin)IBA 05/2017
1	Carcinoembryonic AntigenIBA 01/2017
1	Cell Adhesion MoleculesIBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 03/2016
1	ThioredoxinsIBA 03/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	entinostat (MS 275)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	AntralIBA 06/2011

12	Neoadjuvant Therapy 09/2023 - 02/2013
11	Esophagectomy 09/2023 - 07/2013
10	Drug Therapy (Chemotherapy) 02/2022 - 03/2014
9	Therapeutics 01/2023 - 02/2013
7	Combined Modality Therapy 07/2023 - 03/2014
4	Gastrectomy 10/2022 - 05/2014
4	Pancreaticoduodenectomy 10/2021 - 02/2013
3	Chemoradiotherapy 01/2022 - 01/2015
2	Aftercare (After-Treatment) 12/2021 - 03/2016
2	Length of Stay 02/2017 - 10/2015
2	Ligation 12/2013 - 07/2009
1	Minimally Invasive Surgical Procedures 09/2023
1	Lymph Node Excision (Lymph Node Dissection) 10/2022
1	Immunotherapy 12/2021
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Epidural Analgesia 01/2019
1	Thoracotomy 01/2019
1	Adjuvant Chemoradiotherapy 12/2018
1	Pneumonectomy (Lung Volume Reduction) 12/2017
1	Radiotherapy 12/2017
1	Free Tissue Flaps 12/2017
1	Radiofrequency Ablation 12/2016
1	Hyperthermic Intraperitoneal Chemotherapy 02/2016
1	Subcutaneous Injections 01/2016
1	Stents 05/2014